Expert Opinion on Therapeutic Targets This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 28, 2023 Category: Drugs & Pharmacology Authors: Julia Steinmetz-Sp ähPer-Johan JakobssonDivision of Rheumatology, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden Source Type: research

Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 27, 2023 Category: Drugs & Pharmacology Authors: Cristi L. GalindoSaifur KhanXiangyu ZhangYu-Sheng YehZiyang LiuBabak Razania Vascular Medicine Institute, Department of Medicine, University of Pittsburgh School of Medicine and UPMC, Pittsburgh, PA, United Statesb Department of Cardiology, Pittsburgh VA Source Type: research

Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 24, 2023 Category: Drugs & Pharmacology Authors: Jessica D. JohnsonSalvador AlejoSridharan JayamohanGangadhara R. Sareddya Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, TX, USAb Mays Cancer Center, UT Health San Antonio, San Antonio, TX, USA Source Type: research

Navigating the landscape of psoriasis therapy: novel targeted pathways and emerging trends
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 24, 2023 Category: Drugs & Pharmacology Authors: Srinath InnaniYashika TomarVikas RanaGautam Singhvia Industrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, Indiab Department of Pharmaceutical Sciences and Drug Research, Punjabi unive Source Type: research

Interleukin-18 in cancer immunology and immunotherapy
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 23, 2023 Category: Drugs & Pharmacology Authors: Assunta CirellaIrene OliveraCarlos Luri-ReyElixabet Bola ñosPedro BerraondoIgnacio Meleroa Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spainb Navarra Institute for Health Research (IDISNA), Pamplona, Spainc Centro de I Source Type: research

Targeting cyclin-dependent kinases in rheumatoid arthritis and psoriasis – a review of current evidence
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 20, 2023 Category: Drugs & Pharmacology Authors: Marzena StaniszewskaKajetan Kie łbowskiKlaudia RusińskaEstera BakinowskaEwa GromowskaAndrzej PawlikDepartment of Physiology, Pomeranian Medical University, Szczecin, Poland Source Type: research

Interleukin-1 family cytokines in liver cell death: a new therapeutic target for liver diseases
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 17, 2023 Category: Drugs & Pharmacology Authors: Wanvisa UdomsinprasertDepartment of Biochemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand Source Type: research

CDK6: an attractive therapeutic target for T-ALL/LBL
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 17, 2023 Category: Drugs & Pharmacology Authors: Wei LiJamie Katy HuMiaofen G Hua Department of Medicine, Division of Hematology and Oncology, Tufts Medical Center, Boston, USAb Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, U Source Type: research

Calcium channelopathies in neurodegenerative disorder: an untold story of RyR and SERCA
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 16, 2023 Category: Drugs & Pharmacology Authors: Maanvi DhurejaRichmond ArthurDivya SoniShubham UpadhayayPooja TemgirePuneet KumarDepartment of Pharmacology, Central University of Punjab, Bathinda, India Source Type: research

Curing age-related disease, transforming global medicine
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 30, 2023 Category: Drugs & Pharmacology Authors: Michael FosselTelocyte, Ada, Michigan, USA Source Type: research

Mitochondria makeover: unlocking the path to healthy longevity
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 30, 2023 Category: Drugs & Pharmacology Authors: Andr és CaicedoKeshav K. Singha Universidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBioMed, Quito, Ecuadorb Mito-Act Research Consortium, Quito, Ecuadorc Universidad San Francisco de Quito USFQ, Colegio de Ciencias de la Source Type: research

Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 30, 2023 Category: Drugs & Pharmacology Authors: Jean-Baptiste Assi éDidier Jeana Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité, Functional Genomics of Solid Tumors Laboratory, Paris, Franceb GRC OncoThoParisEst, Service de Pneumologie, Centre Hospitalier Int Source Type: research